FAMULARO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 427
EU - Europa 152
AS - Asia 52
SA - Sud America 2
Totale 633
Nazione #
US - Stati Uniti d'America 424
IT - Italia 91
IN - India 21
UA - Ucraina 20
SE - Svezia 18
CN - Cina 13
SG - Singapore 13
FI - Finlandia 11
FR - Francia 4
TR - Turchia 4
NL - Olanda 3
AR - Argentina 2
CA - Canada 2
DE - Germania 2
IE - Irlanda 2
BG - Bulgaria 1
IR - Iran 1
MX - Messico 1
Totale 633
Città #
Fairfield 77
Ashburn 44
Seattle 38
Woodbridge 34
Chandler 33
Ann Arbor 20
Cambridge 19
Rome 17
Houston 14
Princeton 14
Wilmington 14
Beijing 11
Plano 11
Dearborn 8
Des Moines 8
Cervere 7
Jacksonville 7
Lawrence 6
Millbury 6
San Paolo di Civitate 6
Singapore 6
Boston 5
Istanbul 4
Salerno 4
Verona 4
Andover 3
Bari 3
Deiva Marina 3
Fasano 3
Florence 3
Milan 3
Norwalk 3
Palermo 3
Paris 3
San Diego 3
Vigodarzere 3
Bergamo 2
Calvisano 2
Catanzaro 2
Dalmine 2
Dublin 2
Federal 2
Genoa 2
Leawood 2
Los Angeles 2
Naples 2
Ovada 2
Pescorocchiano 2
Rimini 2
Toronto 2
Bonndorf 1
Falls Church 1
Fremont 1
Hefei 1
Helsinki 1
Indiana 1
Kish 1
Le Casine-Perignano-Spinelli 1
Le Petit-Quevilly 1
Malnate 1
Mannheim 1
Pune 1
Santa Marinella 1
Sesto Fiorentino 1
Shenyang 1
Sofia 1
Washington 1
Totale 495
Nome #
Lymphocyte apoptosis, caspase activation and inflammatory response in septic shock 95
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting. evidence from the REPOSI register 94
CARNITINE DEFICIENCY IN SCLERODERMA 70
Probiotics for the hemodynamic alterations of patients with liver cirrhosis. 70
Oxidative stress and mitochondrial glutathione in human lymphocytes exposed to clinically relevant anesthetic drug concentrations 62
Cyclosporin A-H2 receptor antagonists drug interaction in the sprague-dawley rat. 59
Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis. 51
Polyclonal B lymphocyte activation in progressive systemic sclerosis. 39
Imbalance of immune functions in progressive systemic sclerosis patients 37
Altered carnitine status in patients with systemic sclerosis 24
Alterato metabolismo delle carnitine in pazienti affetti da sclerosi sistemica 24
Livelli plasmatici di peptide vasoativo intestinale (VIP) nei pazienti affetti da sclerosi sistemica 20
Totale 645
Categoria #
all - tutte 2.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.121


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020138 19 2 1 7 14 23 16 17 15 9 13 2
2020/202144 6 6 2 2 4 3 3 3 2 6 4 3
2021/2022102 0 5 8 3 13 2 2 13 7 11 18 20
2022/2023122 26 21 4 9 12 16 2 9 12 0 11 0
2023/2024136 2 15 11 6 15 20 5 20 2 18 12 10
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 645